nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—CYP2D6—Lomustine—brain cancer	0.165	1	CbGbCtD
Hydroxyurea—Radiation injury—Temozolomide—brain cancer	0.0254	0.0448	CcSEcCtD
Hydroxyurea—Fibrosis—Lomustine—brain cancer	0.0243	0.0428	CcSEcCtD
Hydroxyurea—Metastatic neoplasm—Procarbazine—brain cancer	0.023	0.0405	CcSEcCtD
Hydroxyurea—Nail pigmentation—Etoposide—brain cancer	0.0226	0.0399	CcSEcCtD
Hydroxyurea—Azoospermia—Procarbazine—brain cancer	0.0164	0.0289	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—HIC1—brain cancer	0.0161	0.0795	CbGpPWpGaD
Hydroxyurea—Pulmonary fibrosis—Lomustine—brain cancer	0.0158	0.0278	CcSEcCtD
Hydroxyurea—Lung infiltration—Lomustine—brain cancer	0.0148	0.0261	CcSEcCtD
Hydroxyurea—Myelosuppression—Lomustine—brain cancer	0.0148	0.0261	CcSEcCtD
Hydroxyurea—Metastatic neoplasm—Temozolomide—brain cancer	0.0139	0.0245	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—HIC1—brain cancer	0.0133	0.0654	CbGpPWpGaD
Hydroxyurea—Recall phenomenon—Etoposide—brain cancer	0.0123	0.0217	CcSEcCtD
Hydroxyurea—Fibrosis—Carmustine—brain cancer	0.00965	0.017	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Lomustine—brain cancer	0.00899	0.0159	CcSEcCtD
Hydroxyurea—RRM2—G1/S-Specific Transcription—CCNE1—brain cancer	0.00899	0.0444	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—PCNA—brain cancer	0.00796	0.0393	CbGpPWpGaD
Hydroxyurea—Skin necrosis—Carmustine—brain cancer	0.0079	0.0139	CcSEcCtD
Hydroxyurea—Skin hyperpigmentation—Procarbazine—brain cancer	0.00741	0.0131	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Procarbazine—brain cancer	0.00733	0.0129	CcSEcCtD
Hydroxyurea—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.0066	0.0325	CbGpPWpGaD
Hydroxyurea—Neoplasm—Lomustine—brain cancer	0.00628	0.0111	CcSEcCtD
Hydroxyurea—Pulmonary fibrosis—Carmustine—brain cancer	0.00627	0.0111	CcSEcCtD
Hydroxyurea—Skin necrosis—Etoposide—brain cancer	0.00611	0.0108	CcSEcCtD
Hydroxyurea—Pulmonary fibrosis—Temozolomide—brain cancer	0.00606	0.0107	CcSEcCtD
Hydroxyurea—Myelosuppression—Carmustine—brain cancer	0.00588	0.0104	CcSEcCtD
Hydroxyurea—Lung infiltration—Carmustine—brain cancer	0.00588	0.0104	CcSEcCtD
Hydroxyurea—Myelosuppression—Temozolomide—brain cancer	0.00569	0.01	CcSEcCtD
Hydroxyurea—Disorientation—Lomustine—brain cancer	0.00564	0.00994	CcSEcCtD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—CCNE1—brain cancer	0.00529	0.0261	CbGpPWpGaD
Hydroxyurea—Amenorrhoea—Procarbazine—brain cancer	0.00502	0.00885	CcSEcCtD
Hydroxyurea—Pulmonary fibrosis—Etoposide—brain cancer	0.00485	0.00855	CcSEcCtD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—PCNA—brain cancer	0.00468	0.0231	CbGpPWpGaD
Hydroxyurea—Skin hyperpigmentation—Carmustine—brain cancer	0.00464	0.00818	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Carmustine—brain cancer	0.00459	0.00808	CcSEcCtD
Hydroxyurea—Myelosuppression—Etoposide—brain cancer	0.00455	0.00802	CcSEcCtD
Hydroxyurea—RRM2—gonad—brain cancer	0.00453	0.0695	CbGeAlD
Hydroxyurea—RRM1—telencephalon—brain cancer	0.00451	0.0692	CbGeAlD
Hydroxyurea—Febrile neutropenia—Temozolomide—brain cancer	0.00443	0.00781	CcSEcCtD
Hydroxyurea—RRM2—pituitary gland—brain cancer	0.00442	0.0678	CbGeAlD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.0044	0.0217	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00414	0.0204	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Lomustine—brain cancer	0.00414	0.0073	CcSEcCtD
Hydroxyurea—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00409	0.0202	CbGpPWpGaD
Hydroxyurea—Digestion impaired—Temozolomide—brain cancer	0.00399	0.00703	CcSEcCtD
Hydroxyurea—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00393	0.0194	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.00393	0.0194	CbGpPWpGaD
Hydroxyurea—Mucosal inflammation—Etoposide—brain cancer	0.00385	0.00679	CcSEcCtD
Hydroxyurea—Stomatitis—Lomustine—brain cancer	0.00379	0.00668	CcSEcCtD
Hydroxyurea—RRM1—gonad—brain cancer	0.00376	0.0577	CbGeAlD
Hydroxyurea—RRM1—pituitary gland—brain cancer	0.00367	0.0563	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00363	0.0179	CbGpPWpGaD
Hydroxyurea—Disorientation—Procarbazine—brain cancer	0.00358	0.00631	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Carmustine—brain cancer	0.00357	0.0063	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Etoposide—brain cancer	0.00355	0.00625	CcSEcCtD
Hydroxyurea—RRM1—medulla oblongata—brain cancer	0.00354	0.0543	CbGeAlD
Hydroxyurea—Haemoglobin—Lomustine—brain cancer	0.00351	0.00618	CcSEcCtD
Hydroxyurea—Haemorrhage—Lomustine—brain cancer	0.00349	0.00615	CcSEcCtD
Hydroxyurea—Hepatotoxicity—Temozolomide—brain cancer	0.00345	0.00609	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—SIRT1—brain cancer	0.00344	0.017	CbGpPWpGaD
Hydroxyurea—RRM2—endocrine gland—brain cancer	0.00342	0.0525	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.00341	0.0168	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CCNE1—brain cancer	0.0034	0.0168	CbGpPWpGaD
Hydroxyurea—RRM2—head—brain cancer	0.00338	0.0518	CbGeAlD
Hydroxyurea—RRM1—midbrain—brain cancer	0.00324	0.0497	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.00323	0.0159	CbGpPWpGaD
Hydroxyurea—RRM1—spinal cord—brain cancer	0.00316	0.0485	CbGeAlD
Hydroxyurea—RRM2—central nervous system—brain cancer	0.00309	0.0473	CbGeAlD
Hydroxyurea—Alopecia—Lomustine—brain cancer	0.00308	0.00543	CcSEcCtD
Hydroxyurea—Amenorrhoea—Temozolomide—brain cancer	0.00303	0.00535	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—SKP2—brain cancer	0.00303	0.0149	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00296	0.0146	CbGpPWpGaD
Hydroxyurea—RRM1—endocrine gland—brain cancer	0.00284	0.0436	CbGeAlD
Hydroxyurea—RRM2—E2F transcription factor network—SIRT1—brain cancer	0.00284	0.014	CbGpPWpGaD
Hydroxyurea—Hepatic enzyme increased—Temozolomide—brain cancer	0.00282	0.00497	CcSEcCtD
Hydroxyurea—Infection—Carboplatin—brain cancer	0.00281	0.00496	CcSEcCtD
Hydroxyurea—RRM1—head—brain cancer	0.00281	0.0431	CbGeAlD
Hydroxyurea—RRM2—E2F transcription factor network—CCNE1—brain cancer	0.0028	0.0138	CbGpPWpGaD
Hydroxyurea—Hepatotoxicity—Etoposide—brain cancer	0.00276	0.00487	CcSEcCtD
Hydroxyurea—Leukopenia—Lomustine—brain cancer	0.00272	0.00479	CcSEcCtD
Hydroxyurea—Pancreatitis—Procarbazine—brain cancer	0.00271	0.00478	CcSEcCtD
Hydroxyurea—CYP2D6—hindbrain—brain cancer	0.00263	0.0404	CbGeAlD
Hydroxyurea—Skin exfoliation—Carmustine—brain cancer	0.00263	0.00464	CcSEcCtD
Hydroxyurea—Pancytopenia—Procarbazine—brain cancer	0.00263	0.00463	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.00262	0.0129	CbGpPWpGaD
Hydroxyurea—RRM1—central nervous system—brain cancer	0.00256	0.0393	CbGeAlD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—SKP2—brain cancer	0.00255	0.0126	CbGpPWpGaD
Hydroxyurea—Skin exfoliation—Temozolomide—brain cancer	0.00255	0.00449	CcSEcCtD
Hydroxyurea—RRM1—cerebellum—brain cancer	0.00251	0.0384	CbGeAlD
Hydroxyurea—Neoplasm—Carmustine—brain cancer	0.00249	0.0044	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00248	0.0122	CbGpPWpGaD
Hydroxyurea—Drowsiness—Procarbazine—brain cancer	0.00247	0.00435	CcSEcCtD
Hydroxyurea—Infection—Lomustine—brain cancer	0.00246	0.00434	CcSEcCtD
Hydroxyurea—RRM2—brain—brain cancer	0.00245	0.0376	CbGeAlD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00243	0.012	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Lomustine—brain cancer	0.00243	0.00428	CcSEcCtD
Hydroxyurea—Pain—Carboplatin—brain cancer	0.00242	0.00427	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Procarbazine—brain cancer	0.00242	0.00426	CcSEcCtD
Hydroxyurea—Neoplasm—Temozolomide—brain cancer	0.00241	0.00425	CcSEcCtD
Hydroxyurea—Stomatitis—Procarbazine—brain cancer	0.0024	0.00424	CcSEcCtD
Hydroxyurea—Anorexia—Lomustine—brain cancer	0.00236	0.00416	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00235	0.0116	CbGpPWpGaD
Hydroxyurea—Hyperuricaemia—Etoposide—brain cancer	0.0023	0.00405	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK6—brain cancer	0.00227	0.0112	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00226	0.0112	CbGpPWpGaD
Hydroxyurea—Ulcer—Etoposide—brain cancer	0.00226	0.00398	CcSEcCtD
Hydroxyurea—Body temperature increased—Carboplatin—brain cancer	0.00224	0.00395	CcSEcCtD
Hydroxyurea—Haemoglobin—Procarbazine—brain cancer	0.00223	0.00392	CcSEcCtD
Hydroxyurea—Haemorrhage—Procarbazine—brain cancer	0.00221	0.0039	CcSEcCtD
Hydroxyurea—Hallucination—Procarbazine—brain cancer	0.0022	0.00388	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Etoposide—brain cancer	0.00217	0.00383	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.00216	0.0106	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Lomustine—brain cancer	0.00215	0.0038	CcSEcCtD
Hydroxyurea—Hepatic failure—Temozolomide—brain cancer	0.00215	0.0038	CcSEcCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—brain cancer	0.00209	0.0103	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.00206	0.0102	CbGpPWpGaD
Hydroxyurea—Skin exfoliation—Etoposide—brain cancer	0.00204	0.00359	CcSEcCtD
Hydroxyurea—RRM1—brain—brain cancer	0.00204	0.0312	CbGeAlD
Hydroxyurea—RRM2—G1/S Transition—CCNE1—brain cancer	0.00203	0.01	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—brain cancer	0.00199	0.00982	CbGpPWpGaD
Hydroxyurea—Chills—Procarbazine—brain cancer	0.00199	0.0035	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00198	0.00978	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Lomustine—brain cancer	0.00196	0.00345	CcSEcCtD
Hydroxyurea—Alopecia—Procarbazine—brain cancer	0.00196	0.00345	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Etoposide—brain cancer	0.00194	0.00342	CcSEcCtD
Hydroxyurea—Face oedema—Carmustine—brain cancer	0.00193	0.00341	CcSEcCtD
Hydroxyurea—Face oedema—Temozolomide—brain cancer	0.00187	0.00329	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.00186	0.0092	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PPP1R12A—brain cancer	0.00184	0.00909	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PCNA—brain cancer	0.0018	0.00889	CbGpPWpGaD
Hydroxyurea—Anaemia—Procarbazine—brain cancer	0.00178	0.00314	CcSEcCtD
Hydroxyurea—Breast disorder—Temozolomide—brain cancer	0.00175	0.00308	CcSEcCtD
Hydroxyurea—Leukopenia—Procarbazine—brain cancer	0.00173	0.00304	CcSEcCtD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—brain cancer	0.00172	0.0085	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.00171	0.00845	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0017	0.00838	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00168	0.00827	CbGpPWpGaD
Hydroxyurea—Convulsion—Procarbazine—brain cancer	0.00167	0.00294	CcSEcCtD
Hydroxyurea—Pancytopenia—Carmustine—brain cancer	0.00164	0.0029	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—brain cancer	0.00164	0.00809	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00163	0.00803	CbGpPWpGaD
Hydroxyurea—Neutropenia—Carmustine—brain cancer	0.00162	0.00285	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.0016	0.00787	CbGpPWpGaD
Hydroxyurea—Pancytopenia—Temozolomide—brain cancer	0.00159	0.0028	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00158	0.00778	CbGpPWpGaD
Hydroxyurea—Vomiting—Lomustine—brain cancer	0.00158	0.00278	CcSEcCtD
Hydroxyurea—Oedema—Procarbazine—brain cancer	0.00157	0.00277	CcSEcCtD
Hydroxyurea—Dysuria—Temozolomide—brain cancer	0.00156	0.00276	CcSEcCtD
Hydroxyurea—Neutropenia—Temozolomide—brain cancer	0.00156	0.00276	CcSEcCtD
Hydroxyurea—Infection—Procarbazine—brain cancer	0.00156	0.00276	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Procarbazine—brain cancer	0.00154	0.00272	CcSEcCtD
Hydroxyurea—Weight increased—Temozolomide—brain cancer	0.00152	0.00268	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PCNA—brain cancer	0.00152	0.00749	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Carmustine—brain cancer	0.00151	0.00267	CcSEcCtD
Hydroxyurea—CYP2D6—brainstem—brain cancer	0.00151	0.0231	CbGeAlD
Hydroxyurea—Stomatitis—Carmustine—brain cancer	0.0015	0.00265	CcSEcCtD
Hydroxyurea—Anorexia—Procarbazine—brain cancer	0.0015	0.00264	CcSEcCtD
Hydroxyurea—Infestation NOS—Temozolomide—brain cancer	0.00149	0.00263	CcSEcCtD
Hydroxyurea—Infestation—Temozolomide—brain cancer	0.00149	0.00263	CcSEcCtD
Hydroxyurea—Nausea—Lomustine—brain cancer	0.00147	0.00259	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00147	0.00723	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.00146	0.00721	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Temozolomide—brain cancer	0.00146	0.00258	CcSEcCtD
Hydroxyurea—Stomatitis—Temozolomide—brain cancer	0.00145	0.00256	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Temozolomide—brain cancer	0.00141	0.00249	CcSEcCtD
Hydroxyurea—Somnolence—Procarbazine—brain cancer	0.0014	0.00247	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.0014	0.00689	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Carmustine—brain cancer	0.00139	0.00245	CcSEcCtD
Hydroxyurea—Haemorrhage—Carmustine—brain cancer	0.00139	0.00244	CcSEcCtD
Hydroxyurea—Hallucination—Carmustine—brain cancer	0.00138	0.00243	CcSEcCtD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00138	0.00679	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Procarbazine—brain cancer	0.00137	0.00241	CcSEcCtD
Hydroxyurea—Fatigue—Procarbazine—brain cancer	0.00136	0.00239	CcSEcCtD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—brain cancer	0.00135	0.00666	CbGpPWpGaD
Hydroxyurea—Haemoglobin—Temozolomide—brain cancer	0.00135	0.00237	CcSEcCtD
Hydroxyurea—Constipation—Procarbazine—brain cancer	0.00135	0.00237	CcSEcCtD
Hydroxyurea—Pain—Procarbazine—brain cancer	0.00135	0.00237	CcSEcCtD
Hydroxyurea—CYP2D6—telencephalon—brain cancer	0.00134	0.0205	CbGeAlD
Hydroxyurea—Haemorrhage—Temozolomide—brain cancer	0.00134	0.00236	CcSEcCtD
Hydroxyurea—Hallucination—Temozolomide—brain cancer	0.00133	0.00235	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDK4—brain cancer	0.00131	0.00647	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Procarbazine—brain cancer	0.0013	0.00229	CcSEcCtD
Hydroxyurea—Pancytopenia—Etoposide—brain cancer	0.00127	0.00224	CcSEcCtD
Hydroxyurea—Neutropenia—Etoposide—brain cancer	0.00125	0.00221	CcSEcCtD
Hydroxyurea—Body temperature increased—Procarbazine—brain cancer	0.00124	0.00219	CcSEcCtD
Hydroxyurea—Alopecia—Carmustine—brain cancer	0.00122	0.00216	CcSEcCtD
Hydroxyurea—Angiopathy—Temozolomide—brain cancer	0.00121	0.00214	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00121	0.00595	CbGpPWpGaD
Hydroxyurea—Erythema—Carmustine—brain cancer	0.00121	0.00213	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.0012	0.00594	CbGpPWpGaD
Hydroxyurea—Chills—Temozolomide—brain cancer	0.0012	0.00212	CcSEcCtD
Hydroxyurea—Infestation NOS—Etoposide—brain cancer	0.00119	0.0021	CcSEcCtD
Hydroxyurea—Infestation—Etoposide—brain cancer	0.00119	0.0021	CcSEcCtD
Hydroxyurea—Alopecia—Temozolomide—brain cancer	0.00118	0.00209	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.00117	0.00579	CbGpPWpGaD
Hydroxyurea—Neuropathy peripheral—Etoposide—brain cancer	0.00117	0.00206	CcSEcCtD
Hydroxyurea—Erythema—Temozolomide—brain cancer	0.00117	0.00205	CcSEcCtD
Hydroxyurea—Stomatitis—Etoposide—brain cancer	0.00116	0.00205	CcSEcCtD
Hydroxyurea—Hypersensitivity—Procarbazine—brain cancer	0.00116	0.00204	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00114	0.00561	CbGpPWpGaD
Hydroxyurea—Asthenia—Procarbazine—brain cancer	0.00113	0.00199	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Etoposide—brain cancer	0.00113	0.00199	CcSEcCtD
Hydroxyurea—Anaemia—Carmustine—brain cancer	0.00111	0.00197	CcSEcCtD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—brain cancer	0.00111	0.00548	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Temozolomide—brain cancer	0.00108	0.00191	CcSEcCtD
Hydroxyurea—Leukopenia—Carmustine—brain cancer	0.00108	0.0019	CcSEcCtD
Hydroxyurea—Anaemia—Temozolomide—brain cancer	0.00108	0.0019	CcSEcCtD
Hydroxyurea—Diarrhoea—Procarbazine—brain cancer	0.00108	0.0019	CcSEcCtD
Hydroxyurea—Malaise—Temozolomide—brain cancer	0.00105	0.00185	CcSEcCtD
Hydroxyurea—Convulsion—Carmustine—brain cancer	0.00104	0.00184	CcSEcCtD
Hydroxyurea—Leukopenia—Temozolomide—brain cancer	0.00104	0.00184	CcSEcCtD
Hydroxyurea—Dizziness—Procarbazine—brain cancer	0.00104	0.00183	CcSEcCtD
Hydroxyurea—Convulsion—Temozolomide—brain cancer	0.00101	0.00178	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.001	0.00495	CbGpPWpGaD
Hydroxyurea—Vomiting—Procarbazine—brain cancer	0.001	0.00176	CcSEcCtD
Hydroxyurea—Rash—Procarbazine—brain cancer	0.000992	0.00175	CcSEcCtD
Hydroxyurea—Dermatitis—Procarbazine—brain cancer	0.000991	0.00175	CcSEcCtD
Hydroxyurea—Headache—Procarbazine—brain cancer	0.000986	0.00174	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000985	0.00174	CcSEcCtD
Hydroxyurea—Oedema—Carmustine—brain cancer	0.000984	0.00174	CcSEcCtD
Hydroxyurea—Discomfort—Temozolomide—brain cancer	0.00098	0.00173	CcSEcCtD
Hydroxyurea—Infection—Carmustine—brain cancer	0.000978	0.00172	CcSEcCtD
Hydroxyurea—Angiopathy—Etoposide—brain cancer	0.000972	0.00171	CcSEcCtD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000966	0.00476	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Carmustine—brain cancer	0.000964	0.0017	CcSEcCtD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000963	0.00475	CbGpPWpGaD
Hydroxyurea—Chills—Etoposide—brain cancer	0.000961	0.00169	CcSEcCtD
Hydroxyurea—Oedema—Temozolomide—brain cancer	0.000951	0.00168	CcSEcCtD
Hydroxyurea—Alopecia—Etoposide—brain cancer	0.000947	0.00167	CcSEcCtD
Hydroxyurea—Infection—Temozolomide—brain cancer	0.000945	0.00167	CcSEcCtD
Hydroxyurea—Anorexia—Carmustine—brain cancer	0.000938	0.00165	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—SKP2—brain cancer	0.000936	0.00462	CbGpPWpGaD
Hydroxyurea—Nausea—Procarbazine—brain cancer	0.000934	0.00165	CcSEcCtD
Hydroxyurea—Nervous system disorder—Temozolomide—brain cancer	0.000933	0.00164	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Temozolomide—brain cancer	0.000931	0.00164	CcSEcCtD
Hydroxyurea—Skin disorder—Temozolomide—brain cancer	0.000924	0.00163	CcSEcCtD
Hydroxyurea—Anorexia—Temozolomide—brain cancer	0.000907	0.0016	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000882	0.00435	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Carmustine—brain cancer	0.000877	0.00155	CcSEcCtD
Hydroxyurea—Somnolence—Carmustine—brain cancer	0.000875	0.00154	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Etoposide—brain cancer	0.000865	0.00153	CcSEcCtD
Hydroxyurea—Anaemia—Etoposide—brain cancer	0.000862	0.00152	CcSEcCtD
Hydroxyurea—Decreased appetite—Carmustine—brain cancer	0.000856	0.00151	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Carmustine—brain cancer	0.00085	0.0015	CcSEcCtD
Hydroxyurea—Dyspnoea—Temozolomide—brain cancer	0.000848	0.00149	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000847	0.00418	CbGpPWpGaD
Hydroxyurea—Somnolence—Temozolomide—brain cancer	0.000846	0.00149	CcSEcCtD
Hydroxyurea—CYP2D6—endocrine gland—brain cancer	0.000845	0.013	CbGeAlD
Hydroxyurea—Constipation—Carmustine—brain cancer	0.000842	0.00148	CcSEcCtD
Hydroxyurea—Pain—Carmustine—brain cancer	0.000842	0.00148	CcSEcCtD
Hydroxyurea—Malaise—Etoposide—brain cancer	0.000841	0.00148	CcSEcCtD
Hydroxyurea—Dyspepsia—Temozolomide—brain cancer	0.000837	0.00148	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—SKP2—brain cancer	0.000837	0.00413	CbGpPWpGaD
Hydroxyurea—Leukopenia—Etoposide—brain cancer	0.000835	0.00147	CcSEcCtD
Hydroxyurea—CYP2D6—head—brain cancer	0.000834	0.0128	CbGeAlD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK6—brain cancer	0.000834	0.00412	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Temozolomide—brain cancer	0.000827	0.00146	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Temozolomide—brain cancer	0.000821	0.00145	CcSEcCtD
Hydroxyurea—Fatigue—Temozolomide—brain cancer	0.00082	0.00145	CcSEcCtD
Hydroxyurea—Constipation—Temozolomide—brain cancer	0.000813	0.00143	CcSEcCtD
Hydroxyurea—Pain—Temozolomide—brain cancer	0.000813	0.00143	CcSEcCtD
Hydroxyurea—Feeling abnormal—Carmustine—brain cancer	0.000811	0.00143	CcSEcCtD
Hydroxyurea—Convulsion—Etoposide—brain cancer	0.000808	0.00142	CcSEcCtD
Hydroxyurea—RRM2—G1/S Transition—MYC—brain cancer	0.000806	0.00398	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2C9—brain cancer	0.000797	0.00393	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000793	0.00391	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000788	0.00139	CcSEcCtD
Hydroxyurea—Discomfort—Etoposide—brain cancer	0.000784	0.00138	CcSEcCtD
Hydroxyurea—Feeling abnormal—Temozolomide—brain cancer	0.000784	0.00138	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000779	0.00385	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Carmustine—brain cancer	0.000778	0.00137	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000772	0.00381	CbGpPWpGaD
Hydroxyurea—CYP2D6—central nervous system—brain cancer	0.000762	0.0117	CbGeAlD
Hydroxyurea—Infection—Etoposide—brain cancer	0.000756	0.00133	CcSEcCtD
Hydroxyurea—Body temperature increased—Temozolomide—brain cancer	0.000752	0.00133	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDK6—brain cancer	0.000746	0.00368	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Etoposide—brain cancer	0.000745	0.00131	CcSEcCtD
Hydroxyurea—CYP2D6—cerebellum—brain cancer	0.000744	0.0114	CbGeAlD
Hydroxyurea—Skin disorder—Etoposide—brain cancer	0.000739	0.0013	CcSEcCtD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000731	0.00361	CbGpPWpGaD
Hydroxyurea—Anorexia—Etoposide—brain cancer	0.000725	0.00128	CcSEcCtD
Hydroxyurea—Hypersensitivity—Carmustine—brain cancer	0.000725	0.00128	CcSEcCtD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000721	0.00356	CbGpPWpGaD
Hydroxyurea—Asthenia—Carmustine—brain cancer	0.000706	0.00124	CcSEcCtD
Hydroxyurea—Hypersensitivity—Temozolomide—brain cancer	0.000701	0.00124	CcSEcCtD
Hydroxyurea—Asthenia—Temozolomide—brain cancer	0.000682	0.0012	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—brain cancer	0.000679	0.00335	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000679	0.00335	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Etoposide—brain cancer	0.000679	0.0012	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—BSG—brain cancer	0.000678	0.00334	CbGpPWpGaD
Hydroxyurea—Somnolence—Etoposide—brain cancer	0.000677	0.00119	CcSEcCtD
Hydroxyurea—Diarrhoea—Carmustine—brain cancer	0.000673	0.00119	CcSEcCtD
Hydroxyurea—Decreased appetite—Etoposide—brain cancer	0.000662	0.00117	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Etoposide—brain cancer	0.000657	0.00116	CcSEcCtD
Hydroxyurea—Fatigue—Etoposide—brain cancer	0.000656	0.00116	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CYP2C9—brain cancer	0.000656	0.00324	CbGpPWpGaD
Hydroxyurea—Dizziness—Carmustine—brain cancer	0.000651	0.00115	CcSEcCtD
Hydroxyurea—Pain—Etoposide—brain cancer	0.000651	0.00115	CcSEcCtD
Hydroxyurea—Constipation—Etoposide—brain cancer	0.000651	0.00115	CcSEcCtD
Hydroxyurea—Diarrhoea—Temozolomide—brain cancer	0.000651	0.00115	CcSEcCtD
Hydroxyurea—Dizziness—Temozolomide—brain cancer	0.000629	0.00111	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000628	0.0031	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Etoposide—brain cancer	0.000627	0.00111	CcSEcCtD
Hydroxyurea—Vomiting—Carmustine—brain cancer	0.000626	0.0011	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000625	0.00308	CbGpPWpGaD
Hydroxyurea—Rash—Carmustine—brain cancer	0.000621	0.00109	CcSEcCtD
Hydroxyurea—Dermatitis—Carmustine—brain cancer	0.00062	0.00109	CcSEcCtD
Hydroxyurea—Headache—Carmustine—brain cancer	0.000617	0.00109	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000611	0.00302	CbGpPWpGaD
Hydroxyurea—Vomiting—Temozolomide—brain cancer	0.000605	0.00107	CcSEcCtD
Hydroxyurea—CYP2D6—brain—brain cancer	0.000605	0.00927	CbGeAlD
Hydroxyurea—Body temperature increased—Etoposide—brain cancer	0.000602	0.00106	CcSEcCtD
Hydroxyurea—Rash—Temozolomide—brain cancer	0.0006	0.00106	CcSEcCtD
Hydroxyurea—Dermatitis—Temozolomide—brain cancer	0.000599	0.00106	CcSEcCtD
Hydroxyurea—Headache—Temozolomide—brain cancer	0.000596	0.00105	CcSEcCtD
Hydroxyurea—Nausea—Carmustine—brain cancer	0.000585	0.00103	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—IDH1—brain cancer	0.000583	0.00287	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—BRCA2—brain cancer	0.00058	0.00286	CbGpPWpGaD
Hydroxyurea—Nausea—Temozolomide—brain cancer	0.000565	0.000996	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCNE1—brain cancer	0.000562	0.00277	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Etoposide—brain cancer	0.000561	0.000989	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—BSG—brain cancer	0.000558	0.00275	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PCNA—brain cancer	0.000557	0.00275	CbGpPWpGaD
Hydroxyurea—Asthenia—Etoposide—brain cancer	0.000546	0.000963	CcSEcCtD
Hydroxyurea—Diarrhoea—Etoposide—brain cancer	0.000521	0.000918	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000513	0.00253	CbGpPWpGaD
Hydroxyurea—Dizziness—Etoposide—brain cancer	0.000503	0.000887	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—PCNA—brain cancer	0.000498	0.00246	CbGpPWpGaD
Hydroxyurea—Vomiting—Etoposide—brain cancer	0.000484	0.000853	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDK4—brain cancer	0.000481	0.00237	CbGpPWpGaD
Hydroxyurea—Rash—Etoposide—brain cancer	0.00048	0.000846	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—IDH1—brain cancer	0.00048	0.00237	CbGpPWpGaD
Hydroxyurea—Dermatitis—Etoposide—brain cancer	0.000479	0.000845	CcSEcCtD
Hydroxyurea—Headache—Etoposide—brain cancer	0.000477	0.000841	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ENO2—brain cancer	0.000461	0.00227	CbGpPWpGaD
Hydroxyurea—Nausea—Etoposide—brain cancer	0.000452	0.000797	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDK4—brain cancer	0.00043	0.00212	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—ENO2—brain cancer	0.000379	0.00187	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000368	0.00181	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—brain cancer	0.000329	0.00162	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—brain cancer	0.000311	0.00153	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—CCND1—brain cancer	0.000278	0.00137	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—brain cancer	0.000249	0.00123	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—MYC—brain cancer	0.000223	0.0011	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CG—brain cancer	0.000211	0.00104	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—brain cancer	0.000183	0.000903	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CG—brain cancer	0.000174	0.000858	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2C9—brain cancer	0.000125	0.000617	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—BSG—brain cancer	0.000106	0.000525	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—IDH1—brain cancer	9.14e-05	0.000451	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ENO2—brain cancer	7.23e-05	0.000357	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—brain cancer	3.31e-05	0.000164	CbGpPWpGaD
